Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of BBT002 in Healthy Volunteers (HVs) and in Adult Patients With Chronic Obstructive Pulmonary Disease (COPD) or Chronic Rhiosininusitis With Nasal Polyps (CRSwNP)
Sponsor: Bambusa Therapeutics
Summary
Randomized study of single and multiple doses of BBT002 in healthy volunteers and in adult patients with chronic obstructive pulmonary disease (COPD) or chronic rhinosinusitis with nasal polyps (CRSwNP).
Official title: A Randomized, Double-Blind, Placebo-controlled, Single- and Multiple-ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, Pharmacodynamics and Clinical Activity of BBT002 in Healthy Volunteers and Patients With COPD or CRSwNP
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
286
Start Date
2025-05-08
Completion Date
2027-07-31
Last Updated
2026-07-01
Healthy Volunteers
Yes
Conditions
Interventions
BBT002
BBT002 will be administered.
Placebo
Placebo will be administered.
Locations (14)
Equity Medical Bowling Green
Bowling Green, Kentucky, United States
Equity Medical - Owensboro
Owensboro, Kentucky, United States
Equity Medical LLC
New York, New York, United States
Linear Clinical Research
Perth, Western Australia, Australia
Momentum Clinical Research
Brisbane, Australia
Aleksandre Aladashvili Clinic LLC
Tbilisi, Georgia
Geo Hospitals Tbilisi Multiprofile Medical Center
Tbilisi, Georgia
LEPL The First University Clinic of Tbilisi State Medical University
Tbilisi, Georgia
Ltd Aversi Clinic
Tbilisi, Georgia
Momentum Clinical Research Hamilton
Rotorua, Hamilton, New Zealand
Momentum Clinical Research
Pukekohe, New Zealand
Momentum Clinical Research
Wellington, New Zealand
Uniwersyteckie Centrum Kliniczne Osrodka Badan Klinicznych Wczesnych Faz
Gdansk, Poland
Centrum Nowoczesnych Terapii Dobry Lekarz Sp. z o.o.
Krakow, Poland